Cranebio Co.

Medical Devices & EquipmentSeries BTokyo, Japancrane-bio.com

Latest round

Series B

Last raised

Jul 2025

Total raised

$4.3M

Investors

6

About Cranebio Co.

, Ltd. engages in the development and sales of a wearable medical device that detects hormones and diseases specific to women, test kits for infectious diseases such as COVID-19 and Influenza, and rapid test kits for water and food quality testing. The company provides wearable testing kits to advance women’s health. These kits are designed for hormones and women-specific diseases, eliminating the need for invasive blood or urine samples. Cranebio also developed device-free genetic testing kits. These kits boast sensitivity comparable to PCR testing and can be used at home with saliva as the specimen. In addition, the company offers rapid water and food sanitation test kits, providing instant results without the need for specialized equipment. These kits are applicable for infectious disease screening, water quality inspection, and food sanitation assessment, ensuring safety in various settings. The firm’s technology includes Dozyme, a technology harnessing DNA origami scaffolded enzymes that enables the development of highly sensitive medical testing kits for detecting viruses and bacteria, including COVID-19.

Who invested in Cranebio Co.

6 investors across 2 rounds

See all investors in Cranebio Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 31, 2025

    Amount

    $2.6M

    Investors

    Locked

  2. Series A

    Oct 4, 2023

    Amount

    $1.7M

    Investors

    Locked

Questions about Cranebio Co.

Who invested in Cranebio Co.?

Cranebio Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cranebio Co. raised?

Cranebio Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Cranebio Co. last raise money?

Cranebio Co.'s most recent round on record is a Series B, in Jul 2025.

What does Cranebio Co. do?

Cranebio Co. is a medical devices & equipment company.

Where is Cranebio Co. headquartered?

Cranebio Co. is headquartered in Tokyo, Japan.

Which VCs invest in companies like Cranebio Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Cranebio Co.'s stage. Their profiles are linked below.

Raising like Cranebio Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.